Search PubMedSearch

PubMed · 7971847

[Tuberculosis: a new priority].

Abstract

Tuberculosis is one of the most widespread diseases affecting more than 8 million subjects. The death toll has been estimated at 3 million persons annually. In France, the incidence in 1991 was 15 per 100,000 inhabitants with wide regional variation (37 per 100,000 in Paris and surrounding areas). It is difficult to interpret variations in incidence which would appear to be on the rise since 1993. (The increase may be a real rise in incidence or simply due to better registration as a result of reports of HIV infection.) In industrialized countries, economic factors, movements in populations, restrictive policies in antituberculosis health care and HIV infection are all factors leading to an increased incidence in tuberculosis. These observations strongly suggest the need for reorganizing our health care policy in the fight against tuberculosis, improving modern techniques in bacteriological identification and imagining new modalities of prevention and treatment. Special emphasis must be placed on research still required before this curable disease can be eradicated.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Molimard, A Hirsch, J Chrétien. [Tuberculosis: a new priority].. https://pubmed.ncbi.nlm.nih.gov/7971847/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Human papillomavirus infection in women infected with the human immunodeficiency virus.

BACKGROUND: Among women infected with the human immunodeficiency virus (HIV), there is a high prevalence of human papillomavirus (HPV) infections. However, little is known about the natural history of HPV infections in HIV-seropositive women, and persistent HPV infections may explain the increased risk of cervical squamous intraepithelial lesions and invasive cervical cancer in HIV-seropositive women. METHODS: A total of 220 HIV-seropositive and 231 HIV-seronegative women in the New York City area were evaluated at two or more semiannual gynecologic examinations that included a Pap test, a test for HPV DNA, and colposcopy. RESULTS: HPV DNA was detected at the initial examination in 56 percent of the HIV-seropositive and 31 percent of the HIV-seronegative women. After four examinations, the cumulative prevalence of HPV infection was 83 percent in the seropositive women and 62 percent in the seronegative women (P<0.001). Persistent HPV infections were found in 24 percent of the seropositive women but in only 4 percent of the seronegative women (P<0.001). Twenty percent of the seropositive women and 3 percent of the seronegative women had persistent infections with HPV-16-associated viral types (16, 31, 33, 35, or 58) or HPV-18-associated types (18 or 45) (P<0.001), which are most strongly associated with cervical cancer. The detection of HPV DNA in women with previously negative tests was not associated with sexual activity during the interval since the preceding examination. CONCLUSIONS: HIV-seropositive women have a high rate of persistent HPV infections with the types of HPV that are strongly associated with the development of high-grade squamous intraepithelial lesions and invasive cervical cancer. These persistent infections may explain the increased incidence of squamous intraepithelial lesions in HIV-seropositive women.

AIDS-Related Opportunistic Infections